Climb Bio, Inc. (CLYM)
7.25
+0.07
(+0.97%)
USD |
NASDAQ |
Mar 09, 16:00
7.30
+0.05
(+0.69%)
After-Hours: 20:00
Climb Bio Total Assets (Quarterly) : 167.74M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 26.14B |
| Fortress Biotech, Inc. | 181.41M |
| Oramed Pharmaceuticals, Inc. | 220.49M |
| Lyell Immunopharma, Inc. | 407.96M |
| PepGen Inc. | 173.91M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.269M |
| Shareholders Equity (Quarterly) | 160.48M |
| Debt to Equity Ratio | 0.0034 |
| Current Ratio | 15.16 |
| Net Debt Paydown Yield | -0.05% |